Jamie L. Reynoso - Oct 3, 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO, Medicare Advantage
Signature: /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso
Stock symbol: CLOV
Transactions as of: Oct 3, 2024
Transactions value $: -$34,824
Form type: 4
Date filed: 10/7/2024, 04:39 PM
Previous filing: Sep 17, 2024
Next filing: Oct 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Tax liability	-$34.8K	-8.71K	-0.32%	$4.00	2.75M	Oct 3, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

Content

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.